Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer-Reference-Cited by-同舟云学术

Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer

Published:2009-11-10 Issue:3 Volume:10 Page:180-190
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Toffalorio F,Giovannetti E,De Pas T,Radice D,Pelosi G,Manzotti M,Minocci D,Spaggiari L,Spitaleri G,Noberasco C,Catania C,Boselli S,Danesi R,de Braud F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj200953.pdf

Reference50 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.

2. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 2002; 346: 92–98.

3. Rosell R, Cobo M, Isla D, Camps C, Massuti B . Pharmacogenomics and gemcitabine. Ann Oncol 2006; 17 (Suppl 5): v13–v16.

4. Wachters FM, Wong LS, Timens W, Kampinga HH, Groen HJ . ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy. Lung Cancer 2005; 50: 211–219.

5. Shimizu J, Horio Y, Osada H, Hida T, Hasegawa Y, Shimokata K et al. mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. Respirology 2008; 13: 510–517.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines;Biomolecules;2022-04-29

2. JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity;Pharmacogenetics and Genomics;2020-10-16

3. Associations of cytosine deaminase gene polymorphisms with effectiveness of gemcitabine/cisplatin chemotherapy in patients of Xinjiang Uyghur and Han nationality with non-small cell lung cancer;The International Journal of Biological Markers;2019-10-11

4. Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers;npj Genomic Medicine;2019-02-01

5. Molecular Markers for Treatment Response and Toxicity of Gemcitabine;Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy;2019